Johnson & Johnson Will Share Clinical Trial Data — Physician’s First Watch
Johnson & Johnson Will Share Clinical Trial Data
By Larry Husten
In a major victory for advocates of open access to data from clinical trials, Johnson & Johnson has announced that it will make all its clinical trial data available to outside researchers. The company said that the Yale University Open Data Access (YODA) Project will serve as an independent third party "to review requests from investigators and physicians seeking access to anonymized clinical trials data."
Johnson & Johnson said the program "is the first time any company has collaborated with a completely independent third party to review and make decisions regarding every request for clinical data."
"This is a remarkable action ... that should accelerate the movement of the clinical research enterprise toward more cooperative learning and sharing," said Harlan Krumholz, leader of the YODA Project and Editor-in-Chief of NEJM Journal Watch Cardiology. "By establishing this fair and independent process to release data, Johnson & Johnson has taken a leadership position in this emerging era of open science."
Adapted from CardioExchange